Serial 79079371

What this means for you

Registered since 29 Mar 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Mar 2031: the §71 ten-year affidavit of use).

Record

Serial number

79079371

Registration number

3936765

Mark type

Design / logo

Filed

10 Nov 2009

Published for opposition

11 Jan 2011

Registered

29 Mar 2011

Next maintenance filing

§71 ten-year affidavit of use, due by 29 Mar 2031 (grace period to 29 Sept 2031)

Goods and services

• Class 005 — Pharmaceuticals: [ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; agents for immunity adjustment, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system; biological preparations for medical purposes; amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; biopharmaceuticals for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]
• Class 035 — Advertising and business services: Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products
• Class 040 — Treatment of materials: Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals
• Class 042 — Scientific and technological services: Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [ ; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ]
• Class 044 — Medical, beauty and agricultural services: [ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service ]

Owner

• Celltrion Holdings Co.,Ltd., KR
• CELLTRION, INC., Incheon, KR
• CELLTRION, INC., KR
• CELLTRION, INC., KR

Prosecution history

• 21 Oct 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
• 02 Dec 2022 — CHANGE OF NAME/ADDRESS REC'D FROM IB
• 09 Jul 2021 — NEW REPRESENTATIVE AT IB RECEIVED
• 12 Jun 2021 — CHANGE OF OWNER RECEIVED FROM IB
• 01 Apr 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
• 01 Apr 2021 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
• 24 Mar 2021 — TEAS SECTION 71 & 15 RECEIVED
• 22 Mar 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 22 Mar 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 22 Mar 2021 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
• 22 Mar 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 22 Mar 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 22 Mar 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 12 Feb 2021 — NEW REPRESENTATIVE AT IB RECEIVED
• 29 Mar 2020 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED